Literature DB >> 27167142

Anti-Müllerian hormone is all you need: an assisted reproductive technology perspective in diagnosing polycystic ovary syndrome.

Kate McCullough1, William Ledger2.   

Abstract

Entities:  

Keywords:  Rotterdam criteria; anovulatory infertility; anti-Müllerian hormone; assisted reproductive technology; hyperandrogenism; polycystic ovarian morphology; polycystic ovarian syndrome; subfertility

Mesh：

Substances：

Year:  2016        PMID： 27167142      PMCID： PMC5384507          DOI： 10.2217/whe-2016-0005

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN： 1745-5057


× No keyword cloud information.
  14 in total

Review 1.  Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.

Authors:  Human Mousavi Fatemi; Juan Garcia-Velasco
Journal:  Fertil Steril       Date:  2015-02-24       Impact factor: 7.329

Review 2.  An OHSS-Free Clinic by segmentation of IVF treatment.

Authors:  Paul Devroey; Nikolaos P Polyzos; Christophe Blockeel
Journal:  Hum Reprod       Date:  2011-08-09       Impact factor: 6.918

3.  Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?

Authors:  Mette Petri Lauritsen; Anja Pinborg; Anne Loft; Jørgen Holm Petersen; Anne Lis Mikkelsen; Marianne Rich Bjerge; Anders Nyboe Andersen
Journal:  Clin Endocrinol (Oxf)       Date:  2014-11-05       Impact factor: 3.478

Review 4.  Ovarian hyperstimulation syndrome on the acute medical unit: a problem-based review.

Authors:  R Carter; K Petrie; A Sadighi; H Skene
Journal:  Acute Med       Date:  2015

5.  Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.

Authors:  Scott M Nelson; Bjarke M Klein; Joan-Carles Arce
Journal:  Fertil Steril       Date:  2015-01-24       Impact factor: 7.329

6.  Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

Authors:  S Lie Fong; J A Visser; C K Welt; Y B de Rijke; M J C Eijkemans; F J Broekmans; E M Roes; W H M Peters; A C S Hokken-Koelega; B C J M Fauser; A P N Themmen; F H de Jong; I Schipper; J S E Laven
Journal:  J Clin Endocrinol Metab       Date:  2012-09-19       Impact factor: 5.958

7.  Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.

Authors:  Nicolás Crisosto; Bárbara Echiburú; Manuel Maliqueo; Virginia Pérez; Amanda Ladrón de Guevara; Jessica Preisler; Fernando Sánchez; Teresa Sir-Petermann
Journal:  Fertil Steril       Date:  2011-11-14       Impact factor: 7.329

8.  Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries.

Authors:  Robert L Rosenfield; Kristen Wroblewski; Vasantha Padmanabhan; Elizabeth Littlejohn; Monica Mortensen; David A Ehrmann
Journal:  Fertil Steril       Date:  2012-04-26       Impact factor: 7.329

9.  Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.

Authors:  Reshef Tal; David B Seifer; Moisey Khanimov; Henry E Malter; Richard V Grazi; Ben Leader
Journal:  Am J Obstet Gynecol       Date:  2014-03-02       Impact factor: 8.661

10.  Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.

Authors:  Richard A Anderson; Ellen Anckaert; Ernesto Bosch; Didier Dewailly; Cheryl E Dunlop; Daniel Fehr; Luciano Nardo; Johan Smitz; Kelton Tremellen; Barbara Denk; Andrea Geistanger; Martin Hund
Journal:  Fertil Steril       Date:  2015-02-11       Impact factor: 7.329
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.